CASAMENTO CHARLES J
Reporting owner on Forms 3, 4 and 5, CIK 1117167.
CASAMENTO CHARLES J reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-10.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ETON · Eton Pharmaceuticals, Inc.CIK 1710340 | director | 1 | 2026-11-10 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | M exercised | +12,500 | $7.31 | 12,500 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | M exercised | +27,400 | $3.58 | 39,900 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | M exercised | +19,655 | $8.61 | 59,555 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | M exercised | +21,000 | $3.78 | 80,555 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -6,380 | $64.3287 | 74,175 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -14,715 | $65.3249 | 59,460 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -22,601 | $66.2615 | 36,859 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -33,956 | $67.1103 | 2,903 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -2,903 | $67.8695 | 0 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Stock Option, derivative | 2026-11-10 | M exercised | -12,500 | $0 | 0 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Stock Option, derivative | 2026-11-10 | M exercised | -27,400 | $0 | 0 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Stock Option, derivative | 2026-11-10 | M exercised | -19,655 | $0 | 0 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Stock Option, derivative | 2026-11-10 | M exercised | -21,000 | $0 | 29,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-036250 | Eton Pharmaceuticals, Inc. | 2026-11-10 |